The interventional cardiology devices market focuses on medical tools used in minimally invasive procedures to treat heart problems, especially congested or narrowed arteries. These devices include stents, balloons, guidewires, catheters, and imaging systems that help doctors open clogged arteries and restore blood flow without the need for open-heart surgery. These procedures, such as angioplasty and stent placement, offer quicker recovery times, fewer complications, and shorter hospital stays. The Interventional Cardiology Devices Market size is expected to reach US$ 39.23 Billion by 2033 from US$ 18.41 Billion in 2024. The market is estimated to record a CAGR of 8.77% from 2025 to 2033.
The market is growing steadily due to the rising number of people with heart disease, an aging population, and a strong shift toward minimally invasive treatments. Novel technologies such as drug-eluting stents, bioabsorbable scaffolds, and advanced imaging tools are making procedures harmless and more effective. Robotic systems and AI-based tools are also improving accuracy and outcomes.
However, there are still some challenges. These include high device costs, strict approval processes, and limited insurance coverage in some countries. There’s also a risk of problems such as blood clots or artery re-narrowing. Nonetheless, with better access to healthcare in developing countries and more cardiac centers being built, the future of this market looks promising.
You can easily get a sample PDF of the report – https://www.businessmarketinsights.com/sample/BMIPUB00026475
Interventional Cardiology Devices Market Drivers and Opportunities:
Rising Prevalence of Cardiovascular Diseases
Lifestyle changes such as reduced physical activity, unhealthy eating habits, and rising stress levels have contributed to a steady increase in heart-related conditions. In particular, coronary artery disease, heart attacks, and high blood pressure are being diagnosed more frequently, both in urban and rural populations. This growing health burden has created a need for faster, safer, and more accessible treatment options.
For instance, according to an article published in January 2024, by Global Heart, an open-access journal, cardiovascular diseases (CVDs) are the leading cause of mortality globally, responsible for a significant number of deaths and disabilities. In 2021 alone, CVDs accounted for 20.5 million deaths, comprising approximately one-third of all global deaths.
As more people develop heart conditions, the number of such procedures performed in hospitals and specialized centers continues to increase. With cardiovascular diseases becoming more widespread, the demand for interventional cardiology devices is growing steadily, making this a key driver for market expansion.
Rising Demand for PCI Surgeries
Percutaneous Coronary Intervention (PCI), commonly known as angioplasty with stent placement, has firmly established itself as one of the most widely utilized procedures for treating blocked coronary arteries. Its inherently minimally invasive nature, eliminating the need for open surgery, offers significant advantages such as faster patient recovery times and substantially reduced hospital stays. This growing awareness among both patients and physicians regarding its safety, effectiveness, and efficiency has catalyzed a notable shift in preference toward PCI over traditional coronary artery bypass grafting (CABG), particularly for eligible cases.
The market is fueled by the increasing global prevalence of coronary artery disease, an aging population, and unhealthy lifestyles, more patients require this minimally invasive treatment. PCI is the most common procedure to treat blocked coronary arteries. Each surgery necessitates the use of a wide range of devices, including coronary stents, angioplasty balloons, and guide catheters. Consequently, the increasing volume of PCI procedures directly and proportionally drives the consumption and market growth of these essential medical devices.
Interventional Cardiology Devices Market News and Key Development:
The interventional cardiology devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the interventional cardiology devices market are:
- On May 1, 2025, Edwards Lifesciences, an American multinational medical device manufacturing company, announced that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the SAPIEN 3 platform, for severe aortic stenosis (AS) patients without symptoms, marking the first FDA approval for TAVR in asymptomatic patients.
- In March 2024, Boston Scientific Corporation, an American multinational medical device manufacturing company, announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue.
- In May 2024, Abbott, a global healthcare company, announced the launch of XIENCE Sierra Everolimus drug Eluting Coronary Stent System in India. XIENCE Sierra is one of the latest generation stents in the XIENCE family, now available to people suffering from blocked coronary arteries. For interventional cardiologists, it brings unparalleled safety to the most complex cases.
Get Premium Research Report at: https://www.businessmarketinsights.com/buy/BMIPUB00026475
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us:
- If you have any questions about this report or would like further information, please contact us:
- Contact person: Ankit Mathur
- Email: sales@businessmarketinsights.com
- Phone: +16467917070
